Early mineralocorticoid receptor blockade in primary percutaneous coronary intervention for ST-elevation myocardial infarction is associated with a reduction of life-threatening ventricular arrhythmia-Reference-Cited by-同舟云学术

Early mineralocorticoid receptor blockade in primary percutaneous coronary intervention for ST-elevation myocardial infarction is associated with a reduction of life-threatening ventricular arrhythmia

Published:2013-07 Issue:1 Volume:167 Page:73-79
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Beygui Farzin,Labbé Jean-Philippe,Cayla Guillaume,Ennezat Pierre-Vladimir,Motreff Pascal,Roubille François,Silvain Johanne,Barthélémy Olivier,Delarche Nicolas,Van Belle Eric,Collet Jean-Philippe,Montalescot Gilles

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference43 articles.

1. Effects of aldosterone on transient outward K+ current density in rat ventricular myocytes;Benitah;J Physiol,2001

2. Aldosterone upregulates Ca(2+) current in adult rat cardiomyocytes;Benitah;Circ Res,1999

3. Spironolactone and its main metabolite canrenoic acid block hKv1.5, Kv4.3 and Kv7.1 + minK channels;Gomez;Br J Pharmacol,2005

4. Conditional mineralocorticoid receptor expression in the heart leads to life-threatening arrhythmias;Ouvrard-Pascaud;Circulation,2005

5. Aldosterone and the autocrine modulation of potassium currents and oxidative stress in the diabetic rat heart;Shimoni;Br J Pharmacol,2008

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of endogenous mineralocorticoid receptor activity by depressor effects of mineralocorticoid receptor antagonists in patients with primary aldosteronism;Hypertension Research;2024-03-28

2. Serum metabolism characteristics of patients with myocardial injury after noncardiac surgery explored by the untargeted metabolomics approach;BMC Cardiovascular Disorders;2024-02-03

3. Roles of Mineralocorticoid Receptors in Cardiovascular and Cardiorenal Diseases;Annual Review of Physiology;2022-02-10

4. Management of primary aldosteronism and mineralocorticoid receptor-associated hypertension;Hypertension Research;2020-05-18

5. Mineralocorticoid receptor antagonists lead to increased adenosine bioavailability and modulate contractile cardiac parameters;Heart and Vessels;2019-12-09